Serina Therapeutics is a private pharmaceutical company founded in 2006 at the Hudson Alpha Institute of Biotechnology in Huntsville, Alabama. They have developed and patented much of the polymer technology known as PEG, or PEGylation. Peg is accepted widely as the polymer standard and many drugs are developed with this formula. It develops drugs to treat neurological diseases, cancer, pain and refractory epilepsy as well as movement disorders such as Parkinson's disease. The design of this drug is to optimize therapeutic outcomes, safety and quality of life for the patients.